Editorial Note: This report was originally published on January 13, 2026. It has been updated as of September 15, 2026, to reflect the latest developments in the implementation of the U.S. government’s new global health framework.
The landscape of international development is undergoing a tectonic shift. On September 18, 2025, the U.S. government unveiled its "America First Global Health Strategy," a policy overhaul that fundamentally reimagines the relationship between Washington and its partners in the Global South. By moving away from traditional grant-based assistance toward a model of bilateral, performance-based cooperation, the United States is signaling a historic pivot: the era of indefinite, unconditional aid is giving way to an era of "country ownership" and mutual financial responsibility.
At the heart of this strategy are new bilateral health cooperation agreements, structured as Memorandums of Understanding (MOUs). These five-year roadmaps, covering the 2026–2030 period, set a clear objective: the gradual but definitive transition of health systems from U.S. financial support to local fiscal independence.
The Chronology of a Policy Shift
The rollout of this strategy has been rapid and methodical. Following the initial announcement in late 2025, the State Department, in conjunction with the U.S. Agency for International Development (USAID) and various Ministries of Health, initiated a series of diplomatic signings.
- September 2025: The U.S. government releases the "America First Global Health Strategy," defining the criteria for future assistance.
- Late 2025: The first wave of MOUs is signed with partner countries, establishing the legal framework for the 2026–2030 transition period.
- Early 2026: Implementation begins. Partner countries begin reporting their initial co-investment metrics to satisfy the requirements of the agreements.
- September 2026: As of September 11, 2026, the U.S. has formalized 35 agreements. The data tracking these partnerships shows a clear downward trend in U.S. funding, offset by rising expectations for domestic health spending by host nations.
While the majority of these agreements are five-year commitments, the strategy has shown flexibility in its application. For nations such as Bolivia, Botswana, Panama, and South Sudan, the U.S. has opted for three-year accelerated agreements, suggesting a tailored approach based on each nation’s current economic maturity and health system readiness.
Data Analysis: The Fiscal Realignment
A granular look at the data reveals the scale of this transition. An analysis of the 35 signed agreements indicates a collective reduction in U.S. global health funding of approximately $7.5 billion—a 34% decrease compared to historical funding levels (FY21–FY25).
Key Metrics of the Transition
The "America First" strategy is not merely a funding cut; it is a forced reallocation of fiscal responsibility. The data highlights several critical observations:
- Co-Investment Requirements: The core of the MOU is the "co-financing" clause. As U.S. assistance steps down, partner countries are contractually obligated to increase domestic health spending. In the case of Vietnam, for instance, the U.S. has pledged $98.75 million in support, while the Vietnamese government is projected to grow its annual health expenditure by $10.5 billion over the five-year term.
- Strategic Variations: Not all agreements follow the standard MOU template. The Philippines, for example, signed a "Strategic Objective Agreement" rather than a traditional MOU. This deviation highlights that while the U.S. is enforcing a global standard, it remains sensitive to the diplomatic nuances of its key security partners.
- Funding Gaps: The $7.5 billion reduction in U.S. contributions poses a significant challenge for health ministries. The "Grouped Bars" analysis of historical versus proposed funding underscores that for many nations, the transition will require a rapid expansion of local tax bases or a re-prioritization of national budgets to fill the gap left by the U.S. exit.
Official Responses and Diplomatic Positioning
The reception to the "America First" strategy has been mixed, reflecting the diverse priorities of the U.S. and its partners.
From the U.S. Perspective:
U.S. officials argue that the strategy is essential for the long-term sustainability of global health. The rationale, as stated in the policy document, is that "helping countries move toward more resilient and durable health systems" cannot be achieved through perpetual dependence on foreign aid. By requiring co-investment, the U.S. hopes to ensure that health systems are anchored in local political will and fiscal resources, making them less susceptible to the shifting tides of American electoral politics.
From the Partner Perspective:
Ministries of Health in the Global South have expressed both support and concern. Publicly, many governments have praised the move toward "ownership," citing the importance of sovereign control over health policy. Privately, however, there is apprehension regarding the speed of the transition. Critics within the global health community argue that a 34% reduction in U.S. funding over five years may be too aggressive for lower-income countries struggling with post-pandemic debt and rising inflation.
The Implications: A Resilient or Risky Future?
The long-term success of the "America First" Global Health Strategy depends on whether the projected domestic growth in health spending actually materializes. The strategy carries several profound implications:
1. The Risk of Health System Fragility
If partner countries fail to hit their co-financing targets, the resulting funding cliff could lead to the collapse of specific health programs, particularly those focused on infectious disease control, maternal health, and vaccine distribution. The U.S. strategy assumes that economic growth will track with the transition timeline; if the global economy slows, these targets may become unreachable.
2. A Shift in Health Priorities
The program areas targeted by these MOUs suggest a narrower focus. By using keyword searches to categorize health security, it is clear the U.S. is prioritizing outbreak preparedness and the containment of health threats that could pose a risk to U.S. interests. While beneficial, this may lead to a de-prioritization of secondary health issues, such as chronic disease management or long-term infrastructure investment, that do not fall under the "global health security" umbrella.
3. Diplomatic Leverage
The MOU process grants the U.S. a powerful new mechanism for diplomatic leverage. By tying continued financial assistance to the achievement of specific health milestones, the U.S. is effectively embedding health policy into the broader framework of its bilateral relations. This provides Washington with a new tool to demand accountability, but it also risks politicizing health aid, potentially alienating partners who feel the conditions are too onerous.
Conclusion: A New Global Paradigm
The "America First Global Health Strategy" represents a definitive departure from the humanitarian-focused aid models of the early 21st century. It is a pragmatic, if cold, assessment of the limits of U.S. foreign assistance. By demanding that partners "own" their health outcomes, the U.S. is attempting to build a sustainable model of international cooperation.
However, the real-world success of this policy will not be found in the neatly signed MOUs or the projections of domestic spending growth. It will be found in the clinics, laboratories, and health systems of the 35 partner nations. As the implementation phase continues through the remainder of 2026, the global community will be watching closely to see if this pivot creates the "resilient and durable" health systems the U.S. envisions, or if the withdrawal of American support creates a vacuum that leaves the most vulnerable populations at risk.
Data contained in this report is derived from U.S. Department of State press releases, U.S. embassy updates, and documents provided by partner country Ministries of Health. Methodological limitations, particularly the scarcity of full text for some MOUs, mean that this tracker will continue to evolve as more information is made available to the public.
About the Author
